All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Clinical comparison

Etelcalcetide (Parsabiv) vs Sincalide (Kinevac)

An educational, source-based comparison of Etelcalcetide (Parsabiv) and Sincalide (Kinevac) — how each peptide works, what it's researched for, and what to know before going deeper.

Calcium-Sensing Receptor Agonist · Endocrine
Etelcalcetide (Parsabiv)

Calcimimetic peptide for secondary hyperparathyroidism on hemodialysis.

Mechanism

Synthetic D-amino-acid peptide that binds the calcium-sensing receptor on parathyroid chief cells, increasing its sensitivity to extracellular calcium and lowering PTH secretion.

Research areas
  • Secondary hyperparathyroidism in adults on chronic hemodialysis
Considerations
  • FDA-approved.
  • Hypocalcemia common; monitor calcium and avoid in low corrected calcium.
Full Etelcalcetide (Parsabiv) profile →
CCK Analog · Diagnostics
Sincalide (Kinevac)

Synthetic C-terminal octapeptide of cholecystokinin for gallbladder imaging.

Mechanism

Synthetic CCK-8 that binds CCK-A receptors on gallbladder smooth muscle, triggering contraction; used to assess gallbladder ejection fraction in cholescintigraphy.

Research areas
  • Gallbladder ejection fraction (HIDA scan)
  • Pancreatic secretion testing
  • Small bowel transit imaging
Considerations
  • FDA-approved.
  • Abdominal cramping, nausea, diarrhea common; contraindicated in suspected gallstone obstruction.
Full Sincalide (Kinevac) profile →

Etelcalcetide (Parsabiv) vs Sincalide (Kinevac) — Key differences

  • Class: Etelcalcetide (Parsabiv) is classified as Calcium-Sensing Receptor Agonist · Endocrine, while Sincalide (Kinevac) is CCK Analog · Diagnostics.
  • Primary research focus: Etelcalcetide (Parsabiv)secondary hyperparathyroidism in adults on chronic hemodialysis; Sincalide (Kinevac)gallbladder ejection fraction (hida scan).
  • Tag: FDA-Approved · Endocrine vs FDA-Approved · Diagnostics.

Related comparisons